Scienza e Tecnologia
Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting
The Nomination Committee, prior to the 2021 Annual General Meeting, comprises the following members: Laurent Leksell (Chairman), with direct and indirect holdings; Per Colleen , appointed by Fjärde AP-Fonden; Filippa Gerstädt, appointed by Nordea Fonder ; Javiera Ragnartz, appointed by SEB Fonder and Tomas Risbecker, appointed by AMF and AMF Fonder. The chairman of the Nomination Committee is Laurent Leksell .
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25
e-mail: Cecilia.Ketels@elekta.com
Time zone: CET: Central European Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm , Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/elekta/r/elekta-nomination-committee-s-proposed-board-of-directors-for-the-2021-annual-general-meeting,c3360611
The following files are available for download: